NEW YORK (GenomeWeb) – TL Biolabs said today that it recently closed a $4 million round of venture capital financing. The proceeds from the seed round will enable the Santa Clara, California-based company to fund the development and commercial launch of a $15 genomic test for dairy and beef cattle.  

TL Biolabs CEO Fred Turner said in a statement that the firm's new test will "empower farmers to make informed breeding and management decisions and positively impact their bottom line."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.